854P Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN)

Authors :: Rafael Bejar
Amy E. DeZern
Mrinal M. Patnaik
Gabriela S. Hobbs
Selina M. Luger
Gail J. Roboz
Eric Padron
B. Martell
L. Sproat
Mikkael A. Sekeres
M. Leoni
Source :: Annals of Oncology. 32:S783-S784
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine
Phases of clinical research
Chronic myelomonocytic leukemia
Tipifarnib
Hematology
medicine.disease
business
medicine.drug

Full Text Access

Tools